Cell-free Protein Expression Market Revenue to Rise Substantially Owing to Increasing End-use Adoption

Cell-free bio-manufacturing is particularly well-suited for vaccine production due to its potential for rapid scale-up in response to public health emergencies. Successful cell-free expression of a number of recombinant vaccines, such as botulinum, diphtheria, anthrax, and others, have been developed and validated in animal models, such as mice.

In a recent study by Persistence Market Research on the global cell-free protein expression market, it is predicted that the market will grow from US$ 224.7 Mn in 2022 to over US$ 409 Mn by 2032, witnessing high growth of around 6.2% CAGR over the forecast period (2022-2032).

The simple presentation of cell-free protein expression systems makes it easier to integrate them into high-throughput platforms for efficient biologics and proteomics studies. Cell-free protein expression systems, being open systems, allow the addition of various natural and unnatural components to the reaction mixture, such as reducing/oxidizing elements, chaperones, labeled amino acids, or detergents, making this an appropriate choice for different proteomics studies. An increasing number of proteomics and biologics study programs is also expected to boost demand for cell-free protein expression systems.

Click Here to Get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/12385

Increasing expenditure on biosimilar development across the globe and rising application of cell-free protein expression systems in biosimilar research & development is projected to drive market growth over the coming years.

Request For Customization@https://www.persistencemarketresearch.com/request-customization/12385

Key players in the cell-free protein expression market are mainly focusing on acquisitions, collaborations, and partnerships to gain market traction.

In December 2019, the groups from CellFree Sciences Co., Ltd. entered into a collaboration with the Proteo-Science Center, Ehime University (Professor Tatsuya Sawasaki), and developed a new technology to identify proteins meant for binding to target antibodies.
Key Takeaways from Market Study

The E.coli cell-free protein expression systems product segment accounted for the largest share of 48.2% in 2021.
The protein purification application segment held nearly one-third of the global market share in the year 2021.
With over 70% of global revenue share, continuous flow expression dominated the market in 2021.
Amongst the end users, academic and research institutes took the largest bid capturing nearly 44.4% of the market share by revenue globally in 2021.

North America held more than half of the revenue share in the global market in 2021.
"Cell-free protein expression market to witness significant growth owing to growing demand for continuous-exchange cell-free protein synthesis, vaccine production, and production of membrane proteins," says a Persistence Market Research analyst

Click Here to Get this Report@ https://www.persistencemarketresearch.com/checkout/12385

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.